FDA Approves Cymbalta for Maintenance Treatment of Generalized Anxiety Disorder

Nov 30, 2009 -- The U.S. Food and Drug Administration (FDA) has approved Cymbalta(R) (duloxetine HCl) for the maintenance treatment of generalized anxiety disorder (GAD) in adults, Eli Lilly and Company announced today.

The details can be read here.